Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2 John Williams Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2 Read More »
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture John Williams Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture Read More »
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy John Williams Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy Read More »
Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma simplomarketing Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma Read More »
NK cells propagate T cell immunity following in situ tumor vaccination simplomarketing NK cells propagate T cell immunity following in situ tumor vaccination Read More »
HIV vaccines induce CD8+ T cells with low antigen receptor sensitivity John Williams HIV vaccines induce CD8+ T cells with low antigen receptor sensitivity Read More »
Bordetella spp. block eosinophil recruitment to suppress the generation of early mucosal protection John Williams Bordetella spp. block eosinophil recruitment to suppress the generation of early mucosal protection Read More »
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival John Williams AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival Read More »
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy John Williams Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy Read More »
Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression John Williams Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression Read More »
